Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alcidion Group Limited ( (AU:ALC) ) just unveiled an update.
Alcidion Group Limited reported a record-breaking quarter with a positive operating cash flow of $7.4 million, marking the highest in the company’s history. The company achieved significant growth in new sales and contract expansions, notably with North Cumbria Integrated Care NHS Trust, which increased the total contract value to over $39 million. Alcidion ended the fiscal year with a cash balance of $17.7 million and no debt, demonstrating a strong financial position. The company’s continued expansion and deployment of its Miya Precision platform underscore its long-term value proposition and market momentum.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing innovative solutions such as the Miya Precision platform. The company’s primary focus is on enhancing clinical workflows and communication within healthcare settings, with a market focus on expanding its presence through contract expansions and new sales.
Average Trading Volume: 1,401,070
Technical Sentiment Signal: Buy
Current Market Cap: A$161.2M
See more data about ALC stock on TipRanks’ Stock Analysis page.